Ticker
ENVBCompany Name
ENVERIC BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 288.31K | $ -9.94M | $ -9.65M |
3/31/2025 | $ 333.1K | $ -9.3M | $ -8.96M |
12/31/2024 | $ 337.49K | $ -9.57M | $ -9.23M |
9/30/2024 | $ 339.49K | $ -9.83M | $ -9.49M |
6/30/2024 | $ 350.51K | $ -10.57M | $ -10.22M |
3/31/2024 | $ 380.11K | $ -15.04M | $ -14.66M |
12/31/2023 | $ 408.03K | $ -17.27M | $ -16.86M |
9/30/2023 | $ 413.97K | $ -24.02M | $ -23.6M |
6/30/2023 | $ 439.23K | $ -23.68M | $ -23.24M |
3/31/2023 | $ 444.81K | $ -20.11M | $ -19.66M |
EBIT + DepAmor
(=) EBITDA
EBITDA for ENVERIC BIOSCIENCES INC is calculated as follows: EBIT [ $ -5.89M ] + DepAmor [ $ 2.23M ]
(=) EBITDA [ $ -3.66M ]
Minimum
Jun 30, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.24K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.87M |
median | $ 8.87M |
std | $ 166.99M |